Search

Your search keyword '"Biagini E."' showing total 62 results

Search Constraints

Start Over You searched for: Author "Biagini E." Remove constraint Author: "Biagini E." Topic medicine.disease Remove constraint Topic: medicine.disease
62 results on '"Biagini E."'

Search Results

1. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

2. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

3. European Cardiomyopathy Pilot Registry : EURObservational Research Programme of the European Society of Cardiology

4. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

5. Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study

6. The empowerment of translational research: lessons from laminopathies

7. Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey

8. Diagnosis and Management of Cardiovascular Involvement in Fabry Disease

9. The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017

10. Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy

11. Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study

12. Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation

13. Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry

14. The Electrocardiogram in the Diagnosis and Management of Patients with Hypertrophic Cardiomyopathy

15. Kidney transplant in fabry disease: A revision of the literature

16. Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes

17. Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation

18. Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy

19. A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy

20. Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction

21. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies

22. Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy. a systematic review and meta-analysis

23. Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy

24. Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy

25. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

26. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey

27. The Residual Risk of Cerebral Embolism after Carotid Stenting: The Complex Interplay between Stent Coverage and Aortic Arch Atherosclerosis

28. Paradoxical Contributions of Non-Compacted and Compacted Segments to Global Left Ventricular Dysfunction in Isolated Left Ventricular Noncompaction

29. Ventricular remodeling in Loeffler endocarditis: Implications for therapeutic decision making

30. Prognostic Significance of Left Anterior Hemiblock in Patients With Suspected Coronary Artery Disease

31. Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography

32. Comparison of All-Cause Mortality in Women With Known or Suspected Coronary Artery Disease Referred for Dobutamine Stress Echocardiography With Normal Versus Abnormal Test Results

33. Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography

34. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy

35. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy

36. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors

37. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective

38. Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: A retrospective database analysis

39. Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis

40. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction

41. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy

42. Transthyretin-related amyloidoses and the heart: a clinical overview

43. Syncope and risk of sudden death in hypertrophic cardiomyopathy

44. Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy

45. Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy

46. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)

47. Exploring the gap between National Cholesterol Education Program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10 000 patients followed in different specialty settings across Italy

48. Gender-related risk of myocardial involvement in systemic amyloidosis

49. Malperfusion syndrome in type B aortic dissection: role of the endovascular procedures

50. Prenatal echographic recognition of hypertrophic cardiomyopathy leading to heart transplantation in the newborn

Catalog

Books, media, physical & digital resources